Sobre Bristol-Myers Squibb Co.

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Site

bms.com

Setor

PHARMACEUTICAL PREPARATIONS

Funcionários em tempo integral

32.500

Sede

PRINCETON

Data do IPO

Jun 23, 1952